-transparent.png){kind=logo}
Combination chremotherapy with cyclophosphamide, vincristin, adriamycin and DTIC (CyVADIC") was used from 1974 to the middle of 1977 on 12 patients with various forms of metastisising soft-tissue sarcoma. An objective response was observed in seven of eleven patients. Full, although brief, remission occurred in two of six patients with fibrosarcoma and persists in one with an undifferentiated sarcoma. Partial remission was induced in one patients each with fibrosarcoma and alveolar-cell sarcoma. Mean survival time was 18 months. Those responding to treatment had a longer average survival time than those refractory to it. No statistically significant conclusions can be drawn because of the small number of patients, but these observations suggest that this combined treatment can favourable influence previously therapy-refractory forms of metastasising soft-tissue sarcoma.
M Schmidt, and
C P Sodomann, and
C Gropp, and
K Havemann
December 1990,
Onkologie,
M Schmidt, and
C P Sodomann, and
C Gropp, and
K Havemann
August 1986,
Gan no rinsho. Japan journal of cancer clinics,
M Schmidt, and
C P Sodomann, and
C Gropp, and
K Havemann
January 1980,
Cancer treatment reports,
M Schmidt, and
C P Sodomann, and
C Gropp, and
K Havemann
February 1984,
Gan to kagaku ryoho. Cancer & chemotherapy,
M Schmidt, and
C P Sodomann, and
C Gropp, and
K Havemann
January 1982,
European journal of cancer & clinical oncology,
M Schmidt, and
C P Sodomann, and
C Gropp, and
K Havemann
June 1975,
Deutsche medizinische Wochenschrift (1946),
M Schmidt, and
C P Sodomann, and
C Gropp, and
K Havemann
January 1981,
Nephrologie,
M Schmidt, and
C P Sodomann, and
C Gropp, and
K Havemann
January 1981,
Bulletin du cancer,
M Schmidt, and
C P Sodomann, and
C Gropp, and
K Havemann
June 1976,
Deutsche medizinische Wochenschrift (1946),
M Schmidt, and
C P Sodomann, and
C Gropp, and
K Havemann
January 1985,
Cancer chemotherapy and pharmacology,
